Neuraltus Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neuraltus Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10880
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. It develops macrophage which is based on the recent understanding of the fundamental role of inflammation and macrophage activation in chronic neurodegenerative diseases. The company’s products are used for the treatment of neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson’s disease, and Alzheimer’s disease and inherited metaboloic disorders such as fabry’s disease and gaucher’s disease. Neuraltus is headquartered in San Bruno, California, the US.

Neuraltus Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Neuraltus Pharma Raises USD15 Million in Venture Financing 10
Neuraltus Pharma Plans To Raise US$30 Million In Venture Financing 11
Neuraltus Pharma Raises Additional US$1.5 Million In Venture Financing 12
Neuraltus Pharmaceuticals Inc – Key Competitors 13
Neuraltus Pharmaceuticals Inc – Key Employees 14
Neuraltus Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuraltus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neuraltus Pharma Raises USD15 Million in Venture Financing 10
Neuraltus Pharma Plans To Raise US$30 Million In Venture Financing 11
Neuraltus Pharma Raises Additional US$1.5 Million In Venture Financing 12
Neuraltus Pharmaceuticals Inc, Key Competitors 13
Neuraltus Pharmaceuticals Inc, Key Employees 14

List of Figures
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neuraltus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neuraltus Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cathay United Bank Co., Ltd.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Cathay United Bank Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stric …
  • MediaBank, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MediaBank, LLC Mergers and Acqu …
  • Saudi Research and Marketing Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Saudi Research and Marketing Gr …
  • Sumitomo Electric Industries Ltd (5802)-エネルギー分野:企業M&A・提携分析
    Summary Sumitomo Electric Industries, Ltd. (Sumitomo) is a manufacturing company that develops, manufactures, and sells various products related to electronics, infocommunications, automotive, industrial materials, and environment and energy. The company’s product portfolio includes wiring harnesses …
  • SolarWorld AG (SWVK):企業のM&A・提携動向(発電分野)
    Summary SolarWorld AG (SolarWorld) is a vertically-integrated energy company that designs, manufactures, and develops solar power technologies. Its product offerings include raw materials to solar wafers, solar cells, ingots, and solar modules. The company also conducts turnkey construction of large …
  • Kyoei Sangyo Co., Ltd. (6973):企業概要、財務及び戦略的SWOT分析
    Summary Kyoei Sangyo Co., Ltd. (Kyoei Sangyo) is an IT equipment manufacturer. The company operates through its business segment; semiconductors and IC design, electronics devices, materials, industrial system, printed circuit boards and information technology. It supplies semiconductor products, su …
  • MIE Holdings Corporation (1555):企業のM&A・提携動向(石油・ガス分野)
    Summary MIE Holdings Corporation (MIEH), a subsidiary of Far East Energy Limited is an oil and gas company that carries out exploration, development and production activities. The company operates Daan, Moliqing and Miao 3 oilfields in the Songliao Basin. Its Daan oilfield is located in Daan City th …
  • Panhandle Oil and Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Panhandle Oil and Gas Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oi …
  • MGM Resorts International:企業のM&A・提携・投資分析
    MGM Resorts International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MGM Resorts International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Wasko S.A. (WAS):企業財務及び戦略的SWOT分析
    Summary Wasko S.A. (Wasko) is a technology company that develops and markets software, and provides IT services. The company’s products include command support system, city transport management, fleet management, workflow, management of industrial installations, access control and working time regis …
  • Euro-Diagnostica AB:企業のM&A・提携動向(医療機器分野)
    Summary Euro-Diagnostica AB (Euro Diagnostica) is a medical device company that manufactures and markets purified reagents and antibodies. The company offers blood based solutions, developed to aid clinicians in diagnosis, prognosis, monitoring and treatment of autoimmune diseases. It offers its pro …
  • BioVectra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc, is a contract development and manufacturing organization that offers cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients. The organization's products include bioprocessing reagents, diagnostic reagent …
  • Zhuhai Winbase International Chemical Tank Terminal Co., Ltd. (002492):企業の財務及び戦略的SWOT分析
    Summary Zhuhai Winbase International Chemical Tank Terminal Co., Ltd. (Zhuhai Winbase) is a port construction and operating company that specialized in loading and discharging, storage, transferring services, and bonded storage service for liquid chemicals, and petroleum products. The company’s stor …
  • Liberty Bank and Trust Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Liberty Bank and Trust Company …
  • Remy Cointreau:企業の戦略・SWOT・財務分析
    Remy Cointreau - Strategy, SWOT and Corporate Finance Report Summary Remy Cointreau - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • HCC Insurance Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HCC Insurance Holdings, Inc. Me …
  • Gymboree Group, Inc.:企業の戦略的SWOT分析
    Gymboree Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Energy Focus, Inc. (EFOI):企業のM&A・提携動向(発電分野)
    Summary Energy Focus, Inc. (Energy Focus) is a provider of energy efficient LED lighting products and technologies. The company together with its subsidiaries designs, develops, manufactures, markets, and installs the energy-efficient lighting systems and solutions. Its military maritime products in …
  • Biolight AB (BIOL MTF):企業の財務及び戦略的SWOT分析
    Summary Biolight AB (Biolight) is a medical technology company that develops and provides patented system for the treatment of wounds and other inflammatory conditions. The company offers products which are based on the biological effects of dynamic and monochromatic light. It offers hand-held treat …
  • Cohera Medical, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Cohera Medical, Inc. (Cohera) is a medical device company that designs and develops surgical adhesives and sealants for improving patient care. The company offers products such as TissuGlu surgical adhesive, and Sylys surgical sealant. Its TissuGlu surgical adhesive is biocompatible for inte …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆